
Trans-spinal direct current stimulation (tsDCS) can help improve walking and reduce fatigue for people with multiple sclerosis (MS).
In a study with people who have MS, those who received tsDCS showed better walking abilities than those who did not receive this treatment. Specifically, they walked faster and felt less tired after the sessions. The tsDCS group improved their walking times on tests that measure how quickly they can walk short distances. They also reported feeling less fatigue in their daily activities. Overall, this treatment appears to make a significant difference in both walking and energy levels.
MS patients who struggle with walking and feel tired often could find tsDCS helpful in their day-to-day lives. Just like using crutches can support someone who has a leg injury, tsDCS might provide the extra boost needed to walk better and feel less fatigued. Caregivers can also benefit from this knowledge, as helping their loved ones manage fatigue and mobility can improve everyone's quality of life. Healthcare providers may consider adding tsDCS to their treatment plans to better support patients. Overall, these findings could lead to more effective ways to manage MS symptoms.
The study involved a small group of 22 people, so more research is needed to confirm these results on a larger scale. Not everyone may respond the same way to tsDCS, and some people might not see improvement. It's important for patients to discuss this treatment option with their healthcare provider to see if it’s right for them.
1/1/2026
Learn how paramagnetic rim lesions in children with MS relate to brain health and what it means for
Read More1/1/2026
Learn how spinal cord changes in children with MS can signal more serious issues and what it means f
Read More1/1/2026
Discover how high-quality eye scans can lead to better care and outcomes for MS patients with insigh
Read More1/1/2026
Discover how CAR T-cell therapy might change treatment for MS patients, offering new hope for sympto
Read More12/31/2025
Discover how gut bacteria influence multiple sclerosis and explore potential new treatments for mana
Read More12/9/2025
Discover expert recommendations that can improve care for patients with Vanishing White Matter, help
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurologic physical therapy : JNPT often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.